Method Development Approach to Separating Oligonucleotides Under UV and MS Detection
Bonded Phase: OLIGO C18
Conference: EAS
Market Segment: Biopharmaceuticals
Particle Size: 2.7 µm
Pore Size: 120 Å
Product Segment: BIOCLASS
Download FileBonded Phase: OLIGO C18
Conference: EAS
Market Segment: Biopharmaceuticals
Particle Size: 2.7 µm
Pore Size: 120 Å
Product Segment: BIOCLASS
Download File